IRWD

SEC source: 0001209191-21-023576 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO, SVP & Head of Drug Devt.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,514

F1 · kind: The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023.

SEC source: 0001209191-21-023574 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,054

F1 · kind: The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023.

SEC source: 0001209191-21-023573 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President and Interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 568,215

F1 · kind: The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023.

SEC source: 0001209191-21-023572 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,616

F1 · kind: The restricted stock units, granted as a retention award, vest as to 50% of the shares of Class A Common Stock on each of May 19, 2022 and May 18, 2023.

SEC source: 0001209191-21-021299 · doc4.xml · nonDerivative · entry 1

Dreyfus Andrew · CIK 0001670893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,097

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

F2 · balance_after: Since the date of the reporting person's last ownership report, the individual transferred 5,723 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.

SEC source: 0001209191-21-021307 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,079

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

SEC source: 0001209191-21-021296 · doc4.xml · nonDerivative · entry 1

Moukheibir Catherine · CIK 0001772130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,994

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

SEC source: 0001567619-21-006050 · doc1.xml · nonDerivative · entry 3

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 16,390,000

F2 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.

SEC source: 0001567619-21-006050 · doc1.xml · nonDerivative · entry 2

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 16,315,000

F2 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.

SEC source: 0001567619-21-005770 · doc1.xml · nonDerivative · entry 4

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 16,165,000

F2 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.

SEC source: 0001567619-21-005770 · doc1.xml · nonDerivative · entry 3

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,990,000

F2 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.

SEC source: 0001567619-21-005770 · doc1.xml · nonDerivative · entry 2

DENNER ALEXANDER J · CIK 0001361754 · Director · 10% owner

Sarissa Capital Management LP · CIK 0001577524 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 15,740,000

F2 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of Sarissa Capital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.

SEC source: 0001567619-21-005449 · doc1.xml · nonDerivative · entry 4

DENNER ALEXANDER J · CIK 0001361754 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,390,000

F1 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Dr. Denner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC source: 0001567619-21-005449 · doc1.xml · nonDerivative · entry 3

DENNER ALEXANDER J · CIK 0001361754 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 14,890,000

F1 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Dr. Denner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-016108 · doc4.xml · nonDerivative · entry 2

Shetzline Michael · CIK 0001808509 · CMO, SVP & Head of Drug Devt.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,859

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016108 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO, SVP & Head of Drug Devt.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,900

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2019.

SEC source: 0001209191-21-016029 · doc4.xml · nonDerivative · entry 4

Kilroy Conor · CIK 0001808510 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,336

F5 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016029 · doc4.xml · nonDerivative · entry 3

Kilroy Conor · CIK 0001808510 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,184

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.

SEC source: 0001209191-21-016029 · doc4.xml · nonDerivative · entry 2

Kilroy Conor · CIK 0001808510 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,452

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 15, 2018.

SEC source: 0001209191-21-016029 · doc4.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,926

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017.

F2 · balance_after: The reporting person acquired 492 shares of Class A common stock under the issuer's employee stock purchase plan on December 31, 2020.

SEC source: 0001209191-21-016099 · doc4.xml · nonDerivative · entry 4

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,682

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016099 · doc4.xml · nonDerivative · entry 3

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,841

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.

SEC source: 0001209191-21-016099 · doc4.xml · nonDerivative · entry 2

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,038

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.

SEC source: 0001209191-21-016099 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,665

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017.

SEC source: 0001209191-21-016070 · doc4.xml · nonDerivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 471,577

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016070 · doc4.xml · nonDerivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 481,842

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.

SEC source: 0001209191-21-016070 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 483,680

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017.

SEC source: 0001567619-21-005449 · doc1.xml · nonDerivative · entry 2

DENNER ALEXANDER J · CIK 0001361754 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 14,545,100

F1 · ownership.nature: Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Dr. Denner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-016082 · doc4.xml · nonDerivative · entry 1

Owens Edward P · CIK 0001570533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,954

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.88 to $8.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-016044 · doc4.xml · nonDerivative · entry 2

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470,605

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016044 · doc4.xml · nonDerivative · entry 1

Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 493,187

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 9, 2019.

SEC source: 0001209191-21-016018 · doc4.xml · nonDerivative · entry 4

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,244

F4 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.

SEC source: 0001209191-21-016018 · doc4.xml · nonDerivative · entry 3

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,224

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.

SEC source: 0001209191-21-016018 · doc4.xml · nonDerivative · entry 2

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,466

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.

SEC source: 0001209191-21-016018 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,993

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017.

SEC source: 0001209191-21-014866 · doc4.xml · nonDerivative · entry 2

Owens Edward P · CIK 0001570533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,954

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-014866 · doc4.xml · nonDerivative · entry 1

Owens Edward P · CIK 0001570533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,954

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-013772 · doc4.xml · nonDerivative · entry 1

Shetzline Michael · CIK 0001808509 · CMO, SVP & Head of Drug Devt.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,298

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

SEC source: 0001209191-21-013762 · doc4.xml · nonDerivative · entry 1

Rickard Jason · CIK 0001808505 · SVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,333

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

SEC source: 0001209191-21-013751 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486,262

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

SEC source: 0001209191-21-013741 · doc4.xml · nonDerivative · entry 1

Consylman Gina · CIK 0001546358 · SVP, CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,650

F1 · kind: The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

SEC source: 0001209191-20-064043 · doc4.xml · nonDerivative · entry 1

Dreyfus Andrew · CIK 0001670893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,360

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

SEC source: 0001209191-20-064042 · doc4.xml · nonDerivative · entry 1

DENNER ALEXANDER J · CIK 0001361754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,844

F1 · kind: Issued pursuant to the Director Compensation Policy, effective May 2019.

SEC source: 0001209191-20-063819 · doc4.xml · derivative · entry 3

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 99,988 shares

Expires 2021-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option, granted as an annual performance award, was exercisable in full.

SEC source: 0001209191-20-063819 · doc4.xml · nonDerivative · entry 2

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,631

SEC source: 0001209191-20-063819 · doc4.xml · nonDerivative · entry 1

MCCOURT Thomas A · CIK 0001478448 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reporting person acquired 1,885 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2020.

SEC source: 0001209191-20-062229 · doc4.xml · derivative · entry 3

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,639 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option, granted as an annual performance award, is presently exercisable in full.

SEC source: 0001209191-20-062229 · doc4.xml · nonDerivative · entry 2

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,041

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-062229 · doc4.xml · nonDerivative · entry 1

MacDonald Kelly · CIK 0001781117 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-061502 · doc4.xml · nonDerivative · entry 2

Shepard Jay · CIK 0001587788 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,557

F2 · kind: The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.